Does Instacart’s New Exclusivity And Category Expansions Reshape The Bull Case For Maplebear (CART)?
I'm LongbridgeAI, I can summarize articles.Instacart's new exclusivity deals with World Market, Petsense, and expanded services for Costco and Kroger highlight its shift beyond grocery into broader retail categories. For Maplebear (CART), these partnerships deepen retailer integration but do not fundamentally alter the near-term tension between rising costs and the potential for higher-margin software/advertising revenue. The investment narrative projects $5.2B revenue by 2029, though some analysts offer more cautious estimates.
- In August and September 2026, Instacart announced new partnerships making it the exclusive same-day delivery partner for World Market and Petsense, while also expanding its long-term Costco collaboration to include custom cakes and party platters and enabling combined grocery and prescription deliveries for Kroger customers nationwide.
- These agreements strengthen Instacart’s role beyond grocery into home décor, gifts, pet supplies, and pharmacy-enabled orders, highlighting how its marketplace and software tools increasingly underpin retailers’ online and same-day fulfillment capabilities.
- We’ll now examine how Instacart’s exclusive World Market partnership, adding differentiated home and lifestyle products, influences the existing investment narrative.
Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
Maplebear Investment Narrative Recap
To own Maplebear, you need to believe Instacart can turn its retailer network, software, and ads into a durable, profitable infrastructure layer for same day commerce. The World Market, Petsense, Costco, and Kroger announcements all point to deeper integration and broader categories, but they do not fundamentally change the near term tension between rising labor and competition risks and the key catalyst of higher margin software and advertising revenue.
The World Market deal is most closely linked to Instacart’s broader rollout of enterprise tools like Storefront Pro and FoodStorm with retailers such as Costco. Together, these announcements show how Instacart is trying to extend its role from pure grocery delivery into powering differentiated online experiences and perimeter departments, which ties directly into the catalyst of deepening retailer integrations and growing non transaction, higher margin revenue streams.
Yet investors should also weigh how intensifying competition and retailer pressure on fees could affect Instacart’s ability to sustain its current margin profile and...
Read the full narrative on Maplebear (it's free!)
Maplebear’s narrative projects $5.2 billion revenue and $873.2 million earnings by 2029. This requires 9.5% yearly revenue growth and a $401.2 million earnings increase from $472.0 million today.
Uncover how Maplebear's forecasts yield a $57.00 fair value, a 12% upside to its current price.
Exploring Other Perspectives
Some of the lowest analyst estimates assume revenue of about US$4.7 billion and earnings of roughly US$789 million by 2029, which paints a far more cautious picture than the consensus growth narrative tied to Instacart’s expanding partnerships and technology platform.
Explore 3 other fair value estimates on Maplebear - why the stock might be worth just $57.00!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Maplebear research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Maplebear research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Maplebear's overall financial health at a glance.
Ready For A Different Approach?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- Find 47 companies with promising cash flow potential yet trading below their fair value.
- AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Try a Demo Portfolio for Free
